AI brief of an SEC Form 8-K · MILESTONE SCIENTIFIC INC. (MLSS)

Milestone Scientific restructures founder Osser pay deal, adds two independent directors

Neutral Impact 3 of 5 leadership Written later

Milestone Scientific restructured its agreements with founder and former CEO Leonard Osser, cutting his employment compensation by $100,000 to $200,000 per year and increasing his consulting compensation by the same range, with his employment role changed to advisor to the CEO. The Board also appointed Kelly Ulto and Greg Shilling as independent directors, and Benedetta Casamento moved from Chair to Executive Chairman, which changes the Board's leadership and governance structure for shareholders.

Key points

  • Osser agreed to waive past compensation in exchange for payment of $64,080 in past-due amounts and $75,000 as a 1099 catch-up, and his advisor base salary is $48,000 per year through July 17, 2027.
  • On June 19, 2026, the Board appointed Kelly Ulto and Greg Shilling as independent directors; Ulto was named Audit Committee Chair and is designated an audit committee financial expert.
  • Casamento became Executive Chairman and is paid a $75,000 annual salary plus equity awards, along with a one-time $100,000 restricted stock grant vesting July 1, 2026.

The filing

CompanyMILESTONE SCIENTIFIC INC. (MLSS)
Form8-K, current report
Filed with the SECJun 25, 2026, 9:00 AM ET
Accession number0001493152-26-030044

Items reported: 1.01 Material Definitive Agreement5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 25, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.